Monastir University Hospital
Monastir, 5000, Tunisia
NCT Number: NCT03222518
The purpose of this study is to:
Compare the effect of paracetamol alone against NSAIDs alone against the association of paracetamol + NSAIDs in the treatment of traumatic pain.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Monastir, 5000, Tunisia
Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain.
All patients were assigned in a 1:1:1 ratio. Randomization of subjects was performed centrally according to a computer-generated random code provided by one of investigators who was not involved in any other part of the trial. The patients included were divided into 3 groups: Paracetamol group who received paracetamol 1000 mg orally every 8th hour for 7 days; NSAID group who received piroxicam 20 mg orally twice a day for 7 days, and Paracetamol-NSAID combination who received both treatments at the same doses for 7 days. All protocol treatments were administered in opaque packets with code number according to the randomization list by an independent nurse who was not involved in monitoring or follow-up of the individuals. Data were collected for each patient, including demographics, medical history, and findings of the clinical examination. Injury Severity Score (ISS) whose values range from 0 to 75 was also assessed. Each patient was re-evaluated on the 3rd and 7th day post-trauma (D7) using a telephone contact by a clinical research associates who was blinded to the details of the study to note the following clinical data: pain VNS, ED readmissions for residual pain, need for other analgesics other than those of the protocol, other treatment modalities the patient might have used (adherence to the treatment prescribed), and side effects. In addition patients were asked about their satisfaction with pain control following ED using five point Likert scale: very dissatisfied, not satisfied, neutral, satisfied and very satisfied and about the degree to which they adhered to medication schedule. The principal investigator who was aware of the allocation was not involved in monitoring or recording of the outcomes until the data collection was completed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
21 pills of Paracetamol 1000mg are provided with a preconised dose of 1 pill 3 times per day over 7 days period
14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Other names: piroxicam
21 identical pills of paracetamol ith a preconised dose of 1 pill 3 times per day over 7 days period+14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Other names: combination
Time frame: 3 days and 7 days
oral analgesic medications other than those of the protocol prescribed by the treating physicians or taken by patients' own volition
Time frame: 3 and 7 days
[delta VNS= (VNS D0 - VNS D7 / VNS D0) x 100]
Time frame: 7 days
The appearance of side effects: such as Drowsiness ,Decreased respiratory rate (<14 c / min), Cutaneous rash, Vomiting,Nausea,pruritus, Dizziness.
Time frame: 3 and 7 days
ED readmissions for residual pain
Time frame: 3 and 7 days
patient satisfaction assessed by Likert's verbal scale.
University of Monastir
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229965
Acute Pain, Acute Pain Due to Trauma
Monastir, Tunisia
View Trial DetailsNCT01420159
Acute Pain Due to Trauma, Agnosia
Barnsley, United Kingdom
View Trial DetailsNCT06351137
Acute Pain Due to Trauma, Agnosia
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT05630222
Acute Pain Due to Trauma, Multiple Trauma
Isfahan, Iran
View Trial Details